tiprankstipranks
Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
Hong Kong Market
1167
Jacobio Pharmaceuticals Group Co., Ltd.
RESEARCH TOOLSreports
Want to see HK:1167 full AI Analyst Report?

Jacobio Pharmaceuticals Group Co., Ltd. (1167) Stock News & Sentiment

6 Followers
Jacobio Boosts Share Buybacks and Liquidity as Oncology Pipeline Advances
Premium
Company Announcements
Jacobio Boosts Share Buybacks and Liquidity as Oncology Pipeline Advances
4d ago
1167
Jacobio Pharmaceuticals Sets 2026 AGM, Seeks Fresh Share Issuance Mandate
Premium
Company Announcements
Jacobio Pharmaceuticals Sets 2026 AGM, Seeks Fresh Share Issuance Mandate
29d ago
1167
Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
Premium
Company Announcements
Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
2M ago
1167
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
Premium
Ratings
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
2M ago
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
Premium
Company Announcements
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
2M ago
1167
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
3M ago
1167
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
Premium
Company Announcements
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
4M ago
1167
More HK:1167 News >

1167 News on the Web

Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
TipRanks News
Bullish
Huachuang Securities Sticks to Its Buy Rating for Jacobio Pharmaceuticals Group Co., Ltd. (1167)
TipRanks News
Bullish
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
TipRanks News
Bullish
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
TipRanks News
Bullish
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
TipRanks News
Neutral
Jacobio Pharmaceuticals Group Co., Ltd. (1167) Receives a Buy from Huachuang Securities
TipRanks News
Neutral
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
TipRanks News
Bullish
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
HK:1167
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1167’s Media Buzz Sentiment?
1 articles about HK:1167 were published this week. In an average week, 0.25 articles are published.
    What is HK:1167’s weekly average amount of articles?
    In an average week, 0.25 articles about HK:1167 are published.
      What is HK:1167’s News Sentiment?
      100% of articles about HK:1167 were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week